Vaccines
Precision at Scale: Secure Your Vaccine Global Supply Chain
Aventiq Bio delivers independent vaccine consulting and vaccine manufacturing oversight in India
Vaccines
Vaccine programs demand flawless execution at unprecedented scale, yet outsourcing to high-volume facilities introduces risks: lot variability, cold chain breaks, and aseptic breaches that can compromise immunogenicity or trigger recalls.
Aventiq Bio acts as your reliability guardian - delivering independent oversight for antigen integrity, fill-finish mastery, and global access in India's dominant ecosystem.
-
Lot-to-Lot Consistency Variability
Batch #1 differing from Batch #100 in potency or impurities at massive scale.
-
Thermal Stability Profiles
Antigen degradation during storage/transport in diverse climates
-
Aseptic Integrity at Speed
High-speed lines (600+ vials/min) prone to subtle sterility breaches missed in routine audits.
-
Adjuvant-Antigen Compatibility Issues
Poor integration leading to reduced immunogenicity or stability.
-
Analytical Bridge to Potency
In-vitro assays failing to correlate with clinical immune responses
India's Vaccine Dominance – Scale with Precision Potential
India's facilities are unrivaled for volume, with WHO-prequalified sites producing recombinant, subunit, viral vector, and live/attenuated vaccines at billion-dose levels. Strengths include robust cold chain networks, adjuvant expertise, and rapid response capability. The ecosystem supports global tenders and emerging innovations including mRNA vaccine platforms and adjuvanted subunit technologies.
Protecting Potency at Every Transition
We organize oversight around three pillars - ensuring reliability from antigen to global distribution.
Antigen IntegrityExpression System Optimization
- Oversight of CHO, yeast, or bacterial platforms for subunit/recombinant antigens
- Adjuvant-antigen compatibility and immunogenicity advisory
- The Aventiq Edge: Early potency correlation planning to avoid clinical surprises
Fill-Finish Mastery High-Speed Aseptic Governance
- On-ground "Person-in-Plant" monitoring of sterile lines
- Cold-chain stress testing and secondary packaging validation
- The Aventiq Edge: Lot release oversight for batch record consistency
Global Access WHO Prequalification Support
- Site Master File (SMF) audit and dossier alignment
- Viral clearance validation and analytical bridge to potency
Why Aventiq Bio – Your Vaccine Reliability Guardian
Many potent peptides fall under HPAPI classification (OEB 4–5 due to cytotoxicity). We extend our extreme containment expertise to these programs, ensuring safe synthesis, scale-up, and integration - particularly for oncology and ADC applications.
Deep expertise in India's WHO-prequalified, high-volume facilities
Proven lot-to-lot consistency and cold chain programs
On-ground aseptic specialists for real-time intervention
True independence — focused on your vaccine's global impact
Track record supporting recombinant, subunit, and viral vector vaccines